secwatch.observer — SEC 8-K summary
======================================

Issuer:     STREAMLINE HEALTH SOLUTIONS INC. (—)
CIK:        0001008586
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001493152-24-005268
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Streamline Health raises ~$4.5M, modifies credit facility, appoints two directors
--------------------------------------------------------------------------------

- Aggregate gross proceeds ~$4.5M: $4.4M notes bearing 15% interest (maturity 8/7/26) and $100K common stock; warrants for 4,052,631 shares at $0.38 strike.
- Modified Western Alliance Bank credit facility: updated debt-to-EBITDA thresholds, removed minimum cash and max debt-to-ARR covenants, added quarterly adjusted EBITDA targets.
- Appointed CEO Benjamin Stilwill and Matthew Etheridge to board effective Feb 7, 2024; board expanded to seven.
- Company expects liquidity to enable adjusted EBITDA breakeven run rate of $15.5M installed SaaS ARR in H2 fiscal 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/0001493152-24-005268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-005268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer